04/30/2024 7:52 AM | C4 Therapeutics (Filer)
| Form ARS | |
04/29/2024 7:03 AM | C4 Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024 7:04 AM | C4 Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024 3:16 PM | C4 Therapeutics (Issuer) Mossler Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 8:52 AM | C4 Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
03/08/2024 6:28 PM | Boyle Scott N (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:19 PM | C4 Therapeutics (Issuer) Siegel Jolie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/08/2024 6:21 PM | Adams Kendra (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:24 PM | C4 Therapeutics (Issuer) Schick Kelly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:26 PM | C4 Therapeutics (Issuer) Fisher Stewart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 12:11 PM | C4 Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
03/04/2024 6:05 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 8:01 AM | C4 Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024 6:15 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 6:20 AM | C4 Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 5:18 PM | C4 Therapeutics (Issuer) Hirsch Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:21 AM | C4 Therapeutics (Subject) Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024 6:35 AM | C4 Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024 12:04 PM | C4 Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024 9:24 AM | C4 Therapeutics (Subject) Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G | |
02/02/2024 8:34 AM | C4 Therapeutics (Subject) Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/12/2024 3:01 PM | Betta Investment Ltd. (0001990727) (Filed by) C4 Therapeutics (Subject)
| Form SC 13G | |
01/11/2024 6:05 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:15 PM | C4 Therapeutics (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/03/2024 3:12 PM | C4 Therapeutics (Issuer) Dubin Glenn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 3:30 PM | C4 Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
12/22/2023 3:05 PM | C4 Therapeutics (Subject) COMMODORE CAPITAL LP (Filed by)
| Form SC 13G | |
12/12/2023 3:28 PM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 6:15 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2023 3:21 PM | C4 Therapeutics (Issuer) Hughes Owen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:18 PM | C4 Therapeutics (Issuer) Hughes Owen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2023 6:05 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 6:31 AM | C4 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 6:18 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 3:26 PM | C4 Therapeutics (Issuer) GROGAN DONNA ROY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 3:27 PM | C4 Therapeutics (Issuer) Dubin Glenn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 3:28 PM | Anderson Kenneth Carl (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:20 PM | Adams Kendra (Reporting) C4 Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/19/2023 6:20 PM | C4 Therapeutics (Issuer) Mossler Mark (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/19/2023 6:21 PM | Adams Kendra (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:22 PM | C4 Therapeutics (Issuer) Siegel Jolie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing…
Outliving their retirement savings.
You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Click here to register for free. |
09/19/2023 6:23 PM | Boyle Scott N (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:23 PM | C4 Therapeutics (Issuer) Fisher Stewart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:23 PM | C4 Therapeutics (Issuer) Schick Kelly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 6:24 PM | C4 Therapeutics (Issuer) Hirsch Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 6:16 AM | C4 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023 6:09 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 3:05 PM | C4 Therapeutics (Issuer) REYNO LEONARD (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/12/2023 3:06 PM | C4 Therapeutics (Issuer) REYNO LEONARD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 3:35 PM | BlackRock Inc. (Filed by) C4 Therapeutics (Subject)
| Form SC 13G/A | |
06/20/2023 6:11 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:22 PM | C4 Therapeutics (Issuer) Salter Malcolm (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:22 PM | C4 Therapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:23 PM | C4 Therapeutics (Issuer) GROGAN DONNA ROY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:23 PM | C4 Therapeutics (Issuer) Dubin Glenn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:24 PM | C4 Therapeutics (Issuer) DOWNEY BRUCE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:24 PM | Bessen Laura (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 3:25 PM | Anderson Kenneth Carl (Reporting) C4 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 6:30 AM | C4 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |